Overdose of Vinblastine in a Child with Langerhans' Cell Histiocytosis: Toxicity and Salvage Therapy
- 1 January 1991
- journal article
- case report
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 8 (2), 165-169
- https://doi.org/10.3109/08880019109033444
Abstract
The therapeutic index of antineoplastic agents is generally low, therefore, errors in administration can cause severe, life-threatening toxicity. The publication of cases of overdoses may provide useful information on the causes of the mistakes, on drug-induced toxic effects, and on salvage therapy. Hi report a case of vinblastine overdose in a child affected by Langerhans' cell histiocytosis, Hand-Schüller-Christian syndrome according with the previous classification of histiocytosis X. To our knowledge this is the highest dose of vinblastine ever administered. The child was given salvage therapy with steroids and citrovorum factor. Major side effects were neurologic toxicity (seizures, coma) and marrow aplasia, which improved and gradually resolved beginning day 12.Keywords
This publication has 5 references indexed in Scilit:
- Langerhans' cell histiocytosis (Histiocytosis X): Experience at the children's hospital of philadelphia, 1970–1984Medical and Pediatric Oncology, 1989
- An Overdose of VincristinePediatric Hematology and Oncology, 1987
- Folinic Acid Rescue for Vincristine ToxicityClinical Toxicology, 1979
- Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level)The Journal of Pediatrics, 1972
- Death from paralytic ileus following vincristine therapyPublished by Oxford University Press (OUP) ,1970